Stay updated on Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial

Sign up to get notified when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page’s displayed software revision/version number was updated from v3.5.2 to v3.5.3, reflecting a minor update to the ClinicalTrials.gov interface rather than a change to any trial record details.
    Difference
    0.1%
    Check dated 2026-04-24T06:00:34.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Deleted Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:45:01.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Added a new revision (v3.5.0) to the Record History, replacing the previous v3.4.3 entry to reflect an updated study record.
    Difference
    0.1%
    Check dated 2026-03-19T06:20:56.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed from the study record history.
    Difference
    0.1%
    Check dated 2026-03-12T02:28:42.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added; the government-funding notice and the v3.4.1 entry were removed.
    Difference
    0.7%
    Check dated 2026-02-11T14:00:37.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    A site-wide notice about government funding lapse and updated status was added, and the history shows Release Revision: v3.4.1 with v3.4.0 removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2026-02-04T10:14:00.000Z thumbnail image

Stay in the know with updates to Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial page.